WASHINGTON, Aug. 4 -- Bureau of Industry and Security has issued a notice called: Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020.
The notice was published in the Federal Register on Aug. 4 by Jessica Curyto, Deputy Assistant Secretary for Technology Security.
Summary: This notice revises the tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent in accordance with Proclamation 11020 "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States."
The full text of the notice can be found at...